Stocks and Investing Stocks and Investing
Tue, April 19, 2022
[ 12:00 AM ] - WOPRAI
Eric Beaumont Downgraded (CMS) to Hold and Increased Target to $76 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Aaron Rakers Maintained (STX) at Hold with Decreased Target to $90 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Sidney Ho Maintained (STX) at Hold with Decreased Target to $95 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Vincent Caintic Maintained (SYF) at Hold with Decreased Target to $47 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
James Fotheringham Maintained (SYF) at Buy with Increased Target to $52 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Ryan Nash Maintained (SYF) at Strong Buy with Increased Target to $45 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Leo Mariani Maintained (TALO) at Buy with Increased Target to $22 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Simon Flannery Downgraded (TDS) to Hold and Held Target at $22 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
David George Maintained (TFC) at Hold and Held Target at $59 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Adrienne Yih Maintained (TPR) at Buy with Increased Target to $53 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
James Hardiman Maintained (THO) at Hold with Decreased Target to $86 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Mayank Mamtani Maintained (TGTX) at Strong Buy with Decreased Target to $23 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Graig Suvannavejh Maintained (TGTX) at Strong Sell with Decreased Target to $5 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
David Motemaden Maintained (TRV) at Hold and Held Target at $188 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Jimmy Bhullar Maintained (TRV) at Sell and Held Target at $175 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Dan Levy Maintained (TSLA) at Buy with Increased Target to $375 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Barton Crockett Initiated (AAPL) at Hold and Held Target at $184 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Vamil Divan Maintained (ACAD) at Hold with Decreased Target to $27 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
James Fish Maintained (AKAM) at Hold with Increased Target to $126 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
James Hardiman Maintained (BC) at Strong Buy with Decreased Target to $106 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Steve Byrne Downgraded (BG) to Hold on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Steve Byrne Downgraded (ADM) to Hold on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Mark Strouse Maintained (ARRY) at Buy with Decreased Target to $30 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Raimo Lenschow Maintained (APPN) at Sell with Decreased Target to $42 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Eric Sheridan Initiated (APP) at Strong Buy and Held Target at $68 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Greg Gibas Initiated (AMRK) at Buy and Held Target at $53 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Barton Crockett Initiated (AMZN) at Hold and Held Target at $150 on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Brad Erickson Maintained (AMZN) at Buy on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Ritu Baral Initiated (ANTX) at Buy on, Apr 19th, 2022
[ 12:00 AM ] - WOPRAI
Kevin DeGeeter Initiated (ANTX) at Buy and Held Target at $22 on, Apr 19th, 2022

Kevin DeGeeter Initiated (ANTX) at Buy and Held Target at $22 on, Apr 19th, 2022


Published on 2024-10-27 20:30:06 - WOPRAI, Kevin DeGeeter
  Print publication without navigation


Kevin DeGeeter of Oppenheimer, Initiated "AN2 Therapeutics, Inc." (ANTX) at Buy and Held Target at $22 on, Apr 19th, 2022.

Kevin, nor any peers, have made any analyst calls on ANTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources